National Health Investors, Inc. (NYSE:NHI)‘s stock had its “hold” rating reissued by investment analysts at Mizuho in a note issued to investors on Wednesday. They currently have a $82.00 price objective on the real estate investment trust’s stock. Mizuho’s price objective suggests a potential upside of 5.68% from the stock’s previous close.

Several other research firms have also weighed in on NHI. Zacks Investment Research lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, September 6th. KeyCorp reaffirmed a “hold” rating on shares of National Health Investors in a research report on Sunday, September 17th. Finally, BidaskClub raised National Health Investors from a “hold” rating to a “buy” rating in a research report on Thursday, June 29th. One research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $80.20.

Shares of National Health Investors (NYSE NHI) traded down 0.15% during trading on Wednesday, reaching $77.47. The company’s stock had a trading volume of 53,191 shares. National Health Investors has a 52 week low of $66.31 and a 52 week high of $81.21. The company has a market cap of $3.18 billion, a PE ratio of 19.89 and a beta of 0.56. The stock’s 50 day moving average price is $79.15 and its 200 day moving average price is $76.56.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by ($0.36). The company had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The firm’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same period last year, the firm earned $1.22 EPS. Equities research analysts predict that National Health Investors will post $3.85 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “National Health Investors, Inc. (NHI) Rating Reiterated by Mizuho” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/06/national-health-investors-inc-nhi-rating-reiterated-by-mizuho.html.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.19% of the stock is currently owned by insiders.

Several hedge funds have recently bought and sold shares of NHI. BlackRock Inc. increased its holdings in shares of National Health Investors by 6,473.4% during the 1st quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock worth $241,753,000 after acquiring an additional 3,277,930 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of National Health Investors by 3.3% during the 1st quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock worth $451,717,000 after acquiring an additional 201,133 shares during the last quarter. Nuveen Asset Management LLC acquired a new position in shares of National Health Investors during the 1st quarter worth approximately $11,559,000. MARSHALL WACE ASIA Ltd acquired a new position in shares of National Health Investors during the 1st quarter worth approximately $6,794,000. Finally, Marshall Wace North America L.P. acquired a new position in shares of National Health Investors during the 1st quarter worth approximately $6,794,000. 70.67% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.